TE, O., TS, L., CD, H., RF, C., J, W., A, G., . . . WL, S. (2026). Spinal Implant-Associated Infection in Type 2 and Type 1 Diabetes: Phenotype-Specific Inflammatory Features and Therapeutic Response to Semaglutide. JOR spine, 9(2), e70196. https://doi.org/10.1002/jsp2.70196
Chicago Style (17th ed.) CitationTE, Olson, et al. "Spinal Implant-Associated Infection in Type 2 and Type 1 Diabetes: Phenotype-Specific Inflammatory Features and Therapeutic Response to Semaglutide." JOR Spine 9, no. 2 (2026): e70196. https://doi.org/10.1002/jsp2.70196.
MLA (9th ed.) CitationTE, Olson, et al. "Spinal Implant-Associated Infection in Type 2 and Type 1 Diabetes: Phenotype-Specific Inflammatory Features and Therapeutic Response to Semaglutide." JOR Spine, vol. 9, no. 2, 2026, p. e70196, https://doi.org/10.1002/jsp2.70196.